Vascular endothelial growth factor (VEGF) regulates cranial neural crest migration in vivo

Rebecca McLennan1, Jessica M Teddy, Jennifer C Kasemeier-Kulesa

  • 1Stowers Institute for Medical Research, 1000 E. 50th St., Kansas City, MO 64110, USA.

Developmental Biology
|December 29, 2009
PubMed

Insights

Neural crest cell migration into branchial arch 2 is guided by vascular endothelial growth factor (VEGF) chemoattraction. Blocking VEGF disrupts this crucial embryonic developmental pathway.

Area of Science:

  • Developmental Biology
  • Cell Biology
  • Neuroscience

Background:

  • Neural crest cells (NCCs) are crucial for embryonic development.
  • Understanding NCC migration is key to studying developmental processes.
  • Molecular signals guiding NCCs through complex environments remain unclear.

Purpose of the Study:

  • To investigate the role of neuropilin-1 and vascular endothelial growth factor (VEGF) in cranial NCC migration.
  • To test the hypothesis that VEGF chemoattraction directs NCCs into branchial arch 2.

Main Methods:

  • Real-time quantitative PCR (RT-PCR) to analyze gene expression.
  • In vivo experiments involving injection of soluble VEGF receptor 1 (sVEGFR1).
  • In vitro time-lapse imaging to observe NCC behavior towards VEGF sources.

Main Results:

  • VEGF expression patterns correlated with NCC migratory fronts.
  • Blocking VEGF with sVEGFR1 impaired NCC invasion of branchial arch 2.
  • NCCs exhibited directed migration towards VEGF sources in vitro.

Conclusions:

  • Neuropilin-1 and VEGF signaling are critical for NCC entry and invasion of branchial arch 2.
  • VEGF acts as a chemoattractant guiding cranial NCCs.
  • This study proposes a model for NCC migration dependent on VEGF-mediated chemoattraction.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Determination01:51

Determination

During embryogenesis, cells become progressively committed to different fates through a two-step process: specification followed by determination. Specification is demonstrated by removing a segment of an early embryo, “neutrally” culturing the tissue in vitro—for example, in a petri dish with simple medium—and then observing the derivatives. If the cultured region gives rise to cell types that it would normally generate in the embryo, this means that it is specified. In contrast, determination...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...